252 related articles for article (PubMed ID: 23766854)
1. Enhanced 4-hydroxynonenal resistance in KEAP1 silenced human colon cancer cells.
Jung KA; Kwak MK
Oxid Med Cell Longev; 2013; 2013():423965. PubMed ID: 23766854
[TBL] [Abstract][Full Text] [Related]
2. Identification of aldo-keto reductases as NRF2-target marker genes in human cells.
Jung KA; Choi BH; Nam CW; Song M; Kim ST; Lee JY; Kwak MK
Toxicol Lett; 2013 Mar; 218(1):39-49. PubMed ID: 23305850
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide activation of Keap1/Nrf2 signaling in human colon carcinoma cells.
Li CQ; Kim MY; Godoy LC; Thiantanawat A; Trudel LJ; Wogan GN
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14547-51. PubMed ID: 19706542
[TBL] [Abstract][Full Text] [Related]
4. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
Habib E; Linher-Melville K; Lin HX; Singh G
Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
[TBL] [Abstract][Full Text] [Related]
5. Aldo-Keto Reductase Regulation by the Nrf2 System: Implications for Stress Response, Chemotherapy Drug Resistance, and Carcinogenesis.
Penning TM
Chem Res Toxicol; 2017 Jan; 30(1):162-176. PubMed ID: 27806574
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29.
Ebert B; Kisiela M; Wsól V; Maser E
Chem Biol Interact; 2011 May; 191(1-3):239-49. PubMed ID: 21215737
[TBL] [Abstract][Full Text] [Related]
7. Cytoprotection against beta-amyloid (Aβ) peptide-mediated oxidative damage and autophagy by Keap1 RNAi in human glioma U87mg cells.
Youn P; Chen Y; Furgeson DY
Neurosci Res; 2015 May; 94():70-8. PubMed ID: 25612817
[TBL] [Abstract][Full Text] [Related]
8. The autophagy pathway maintained signaling crosstalk with the Keap1-Nrf2 system through p62 in auditory cells under oxidative stress.
Hayashi K; Dan K; Goto F; Tshuchihashi N; Nomura Y; Fujioka M; Kanzaki S; Ogawa K
Cell Signal; 2015 Feb; 27(2):382-93. PubMed ID: 25435427
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds.
MacLeod AK; McMahon M; Plummer SM; Higgins LG; Penning TM; Igarashi K; Hayes JD
Carcinogenesis; 2009 Sep; 30(9):1571-80. PubMed ID: 19608619
[TBL] [Abstract][Full Text] [Related]
10. Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells.
Zhan L; Zhang H; Zhang Q; Woods CG; Chen Y; Xue P; Dong J; Tokar EJ; Xu Y; Hou Y; Fu J; Yarborough K; Wang A; Qu W; Waalkes MP; Andersen ME; Pi J
Free Radic Biol Med; 2012 Aug; 53(4):758-68. PubMed ID: 22684020
[TBL] [Abstract][Full Text] [Related]
11. KEAP1/NRF2 axis regulates H
He J; Zhang X; Lian C; Wu J; Fang Y; Ye X
Gene; 2019 Apr; 691():8-17. PubMed ID: 30594636
[TBL] [Abstract][Full Text] [Related]
12. Cross-regulations among NRFs and KEAP1 and effects of their silencing on arsenic-induced antioxidant response and cytotoxicity in human keratinocytes.
Zhao R; Hou Y; Zhang Q; Woods CG; Xue P; Fu J; Yarborough K; Guan D; Andersen ME; Pi J
Environ Health Perspect; 2012 Apr; 120(4):583-9. PubMed ID: 22476201
[TBL] [Abstract][Full Text] [Related]
13. The cytoprotective role of the Keap1-Nrf2 pathway.
Baird L; Dinkova-Kostova AT
Arch Toxicol; 2011 Apr; 85(4):241-72. PubMed ID: 21365312
[TBL] [Abstract][Full Text] [Related]
14. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
[TBL] [Abstract][Full Text] [Related]
15. Four-octyl itaconate activates Keap1-Nrf2 signaling to protect neuronal cells from hydrogen peroxide.
Liu H; Feng Y; Xu M; Yang J; Wang Z; Di G
Cell Commun Signal; 2018 Nov; 16(1):81. PubMed ID: 30442144
[TBL] [Abstract][Full Text] [Related]
16. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.
Eades G; Yang M; Yao Y; Zhang Y; Zhou Q
J Biol Chem; 2011 Nov; 286(47):40725-33. PubMed ID: 21926171
[TBL] [Abstract][Full Text] [Related]
17. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells.
Yang SP; Yang XZ; Cao GP
Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
[TBL] [Abstract][Full Text] [Related]
19. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species.
Reisman SA; Yeager RL; Yamamoto M; Klaassen CD
Toxicol Sci; 2009 Mar; 108(1):35-47. PubMed ID: 19129213
[TBL] [Abstract][Full Text] [Related]
20. Functional dissection of Nrf2-dependent phase II genes in vascular inflammation and endotoxic injury using Keap1 siRNA.
Kim JH; Choi YK; Lee KS; Cho DH; Baek YY; Lee DK; Ha KS; Choe J; Won MH; Jeoung D; Lee H; Kwon YG; Kim YM
Free Radic Biol Med; 2012 Aug; 53(3):629-40. PubMed ID: 22609006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]